Co-Diagnostics developing test for new coronavirus

By staff writers

January 23, 2020 -- Molecular diagnostics company Co-Diagnostics has completed design work for a test to screen for the new coronavirus behind an outbreak in China.

The 2019 novel coronavirus (2019-nCoV) can cause pneumonia-like respiratory illness and has spread rapidly after first being discovered in Wuhan, China, late last year.

The design for Co-Diagnostics' polymerase chain reaction (PCR) test features the company's CoPrimer technology. It follows guidelines from the World Health Organization and U.S. Centers for Disease Control and Prevention to help screen for the quickly spreading virus.

Genetics show deadly Wuhan coronavirus sired by snakes
The roots of the potentially deadly novel coronavirus that emerged in humans in Wuhan, China, and is spreading to other countries lie in snakes, according...
CDC says traveler brought China coronavirus to U.S.
A resident of Washington state has been found to be infected with a new type of coronavirus that originated in China, according to the U.S. Centers for...
CDC takes action amid novel coronavirus outbreak in China
The U.S. Centers for Disease Control and Prevention (CDC) is closely monitoring the new coronavirus outbreak in the large Central China city of Wuhan...
Roche launches adenovirus PCR test in Europe
Roche has launched a real-time polymerase chain reaction (PCR) screening test for transplant patients at risk of adenovirus infection in countries that...
In a first for U.S., FDA clears OraQuick rapid Ebola test
OraSure Technologies' OraQuick has become the first rapid diagnostic for detecting Ebola virus antigens to win marketing clearance from the U.S. Food...

Copyright © 2020

Last Updated np 2/21/2020 2:08:52 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current